Fludarabine phosphate

Download report

Favorite

Events Timeline

Commercial

Clinical

Drug

Target

Variants

Financial

Trends

Safety

Events Timeline

YTD

Max

Events

FDA approval date

EMA approval date

Patent expiration date

Study first post date

Last update post date

Start date

Primary completion date

Completion date

Results first post date

Mock data
Subscribe for the real data

Commercial

No data

Clinical

Clinical Trials

2479 clinical trials

Mock data
Subscribe for the real data

Indications Phases 4

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Leukemia	D007938	—	C95	313	424	80	13	50	739
Myeloid leukemia acute	D015470	—	C92.0	194	276	59	6	29	483
Lymphoma	D008223	—	C85.9	245	257	25	3	36	475
Myelodysplastic syndromes	D009190	—	D46	130	270	26	2	30	400
Precursor cell lymphoblastic leukemia-lymphoma	D054198	—	C91.0	178	205	18	5	27	367
B-cell chronic lymphocytic leukemia	D015451	—	C91.1	122	192	37	3	19	324
Non-hodgkin lymphoma	D008228	—	C85.9	163	167	14	1	23	305
Multiple myeloma	D009101	—	C90.0	131	143	11	1	28	280
Lymphoid leukemia	D007945	—	C91	130	148	32	7	14	278
Myeloid leukemia	D007951	—	C92	100	154	34	3	14	257

Show 17 more

Indications Phases 3

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Neoplasms	D009369	—	C80	175	113	4	—	17	257
Bcr-abl positive chronic myelogenous leukemia	D015464	EFO_0000340	—	34	114	6	—	11	146
Hodgkin disease	D006689	—	C81	52	95	3	—	16	143
Follicular lymphoma	D008224	—	C82	48	68	14	—	8	124
Mantle-cell lymphoma	D020522	—	C83.1	48	65	9	—	9	114
Melanoma	D008545	—	—	58	64	1	—	2	106
Anemia	D000740	EFO_0004272	D64.9	22	52	9	—	10	74
Aplastic anemia	D000741	—	D61.9	14	47	6	—	16	71
Myelomonocytic leukemia chronic	D015477	—	C93.1	25	46	2	—	7	68
B-cell lymphoma marginal zone	D018442	—	C88.4	25	36	2	—	8	66

Show 53 more

Indications Phases 2

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Ovarian neoplasms	D010051	EFO_0003893	C56	47	23	—	—	—	57
T-cell lymphoma	D016399	—	—	25	33	—	—	3	52
Carcinoma	D002277	—	C80.0	41	17	—	—	3	51
Systemic lupus erythematosus	D008180	EFO_0002690	M32	42	11	—	—	2	46
Breast neoplasms	D001943	EFO_0003869	C50	34	24	—	—	—	45
Renal cell carcinoma	D002292	EFO_0000376	—	29	21	—	—	3	43
Myeloid leukemia accelerated phase	D015465	—	—	9	32	—	—	5	41
Plasmacytoma	D010954	—	C90.3	13	22	—	—	6	38
Non-small-cell lung carcinoma	D002289	—	—	30	14	—	—	—	37
Lung neoplasms	D008175	—	C34.90	33	13	—	—	—	36

Show 283 more

Indications Phases 1

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Autoimmune diseases of the nervous system	D020274	—	—	6	—	—	—	—	6
Rhabdoid tumor	D018335	—	—	5	—	—	—	—	5
Small cell lung carcinoma	D055752	—	—	4	—	—	—	—	4
Wilms tumor	D009396	EFO_0000212	—	4	—	—	—	—	4
Female genital neoplasms	D005833	—	—	4	—	—	—	—	4
Nervous system diseases	D009422	—	G00-G99	3	—	—	—	—	3
Kidney diseases	D007674	EFO_0003086	N08	3	—	—	—	—	3
Alveolar soft part sarcoma	D018234	—	—	3	—	—	—	—	3
Medulloblastoma	D008527	—	—	2	—	—	—	—	2
Ependymoma	D004806	—	—	2	—	—	—	—	2

Show 65 more

Indications Without Phase

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Abnormal karyotype	D059786	—	—	—	—	—	—	1	1
Hemoglobin c disease	D006445	—	D58.2	—	—	—	—	1	1
Mucositis	D052016	EFO_1001898	—	—	—	—	—	1	1
Hereditary congenital and neonatal diseases and abnormalities	D009358	—	—	—	—	—	—	1	1
Monoclonal gammopathy of undetermined significance	D008998	EFO_1000836	D47.2	—	—	—	—	1	1
Primary graft dysfunction	D055031	—	—	—	—	—	—	1	1